![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pain Res. , 11 April 2023
Sec. Neuromodulatory Interventions
Volume 4 - 2023 | https://doi.org/10.3389/fpain.2023.1190014
This article is part of the Research Topic Pain 360: Emerging Topics in the Pathophysiology, Diagnosis, and Treatment of Chronic Pain View all 6 articles
This article is a correction to:
Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient
A Corrigendum on
Intrathecal drug delivery: Advances and applications in the management of chronic pain patient
By De Andres J, Hayek S, Perruchoud Ch, Lawrence MM, Reina MA, De Andres-Serrano C, Rubio-Haro R, Hunt M and Yaksh TL. (2022) Front. Pain Res. 3:900566 doi: 10.3389/fpain.2022.900566
In the published article, there was an error in the figure and legend of Figure 9. In the incorrect figure, the two columns of recording are switched. The T = 15 s image should be T = 240 s and the T = 240 image should be T = 15 s. The corrected figure is the same except the images switched to correct for the mislabeled timing. The figure legend is now as follows.
“FIGURE 9 Two-dimensional diffusion chamber with a catheter having 20 microports. Images taken at 15 s (top, left) and 240 s (bottom, left), following bolus delivery of 2.6 µl as a bolus at time 0. The image on the right of the T = 15 s image shows an enlargement of the high velocity stream exiting the catheter at two of the exit valves, with the characteristic mushroom head where dye laden solute encounters the local dye-free fluid phase. Note the even distribution of dye from proximal (pump) to distal over the 6-cm catheter distance (T. L. Yaksh)”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: antisense, intrathecal, neuromodulation, chronic pain, implantable drug delivery system (IDDS)
Citation: De Andres J, Hayek S, Perruchoud C, Lawrence MM, Reina MA, De Andres-Serrano C, Rubio-Haro R, Hunt M and Yaksh TL (2023) Corrigendum: Intrathecal drug delivery: Advances and applications in the management of chronic pain patient. Front. Pain Res. 4:1190014. doi: 10.3389/fpain.2023.1190014
Received: 20 March 2023; Accepted: 23 March 2023;
Published: 11 April 2023.
Edited and Reviewed by: Michael D. Staudt, Oakland University William Beaumont School of Medicine, United States
© 2023 De Andres, Hayek, Perruchoud, Lawrence, Reina, De Andres-Serrano, Rubio-Haro, Hunt and Yaksh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jose De Andres ZGVhbmRyZXNfam9zQGd2YS5lcw==
Specialty Section: This article was submitted to Neuromodulatory Interventions, a section of the journal Frontiers in Pain Research
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.